4th Quarter - Termination

AVENUE SOLUTIONS for ALLIANCE FOR REGENERATIVE MEDICINE

Firm
Client
Income
$50,000
Expenses
—
Terminated
Dec 31, 2025

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 1509/S. 752, Accelerating Kids Access to Care Act; H.R. 1262/S. 932, Give Kids a Chance Act; S. 1637, MVP Act of 2025; Issues related to regulation of, access to, and reimbursement for regenerative medicine companies and products

LobbyistCovered position, as disclosed
MATTHEW FUENTES —
JORDAN A LACROSSE —
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1637 (119th), H.R. 1509 (119th), S. 752 (119th), S. 932 (119th), H.R. 1262 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.